News

Research Report:

http://www.taglichbrothers.com/equityuniverse/companies/pivotaltherapeutics/pivotaltherapeutics.aspx

Business Strategy

• Maximizing investor’s return and minimize product development risk through a re-profiling strategy
• Selecting drugs with proven efficacy and safety
• Creating novel formulations
• New clinical indications and market positioning
• New intellectual property (IP) protecting new formulations and indications
• Quicker realization of revenues with less risky strategies to bring products to market sooner

Links

Canadian National Stock Exchange (CNSX)
System for Electronic Document Analysis and Retrieval (SEDAR)